gptkbp:instance_of
|
gptkb:medical_devices
|
gptkbp:acquisition
|
gptkb:De_Puy_Synthes
gptkb:Ethicon
gptkb:Biosense_Webster
Cerenovus
|
gptkbp:ceo
|
gptkb:Joaquin_Duato
|
gptkbp:clinical_trial
|
Ongoing
|
gptkbp:community_engagement
|
Disaster Relief Efforts
Health Initiatives
Education Programs
Volunteer Programs
Partnerships with NGOs
|
gptkbp:employees
|
Over 40,000
|
gptkbp:focus_area
|
gptkb:Insurance_Company
Neuroscience
Orthopedics
Cardiovascular Health
Surgical Solutions
Interventional Solutions
|
gptkbp:founded
|
1886
|
gptkbp:headquarters
|
gptkb:New_Brunswick,_New_Jersey
|
https://www.w3.org/2000/01/rdf-schema#label
|
Johnson & Johnson Medical Devices
|
gptkbp:innovation
|
gptkb:Robotic_Surgery_Systems
3 D Printing Technology
Digital Surgery Solutions
|
gptkbp:market_position
|
gptkb:Europe
gptkb:Middle_East
gptkb:Latin_America
gptkb:North_America
gptkb:Asia-Pacific
|
gptkbp:operates_in
|
Global Market
|
gptkbp:parent_company
|
gptkb:Johnson_&_Johnson
|
gptkbp:part_of
|
gptkb:Johnson_&_Johnson
|
gptkbp:partnership
|
gptkb:World_Health_Organization
gptkb:American_College_of_Surgeons
Med Tech Innovator
|
gptkbp:products
|
Orthopedic Devices
Surgical Instruments
Cardiovascular Devices
Neurosurgical Devices
|
gptkbp:regulatory_compliance
|
FDA Approved
CE Mark Certified
|
gptkbp:research_and_development
|
$1.5 billion (2020)
|
gptkbp:revenue
|
$26 billion (2020)
|
gptkbp:sustainability_initiatives
|
Environmental Stewardship
Carbon Neutrality Goals
Sustainable Packaging
Waste Reduction Programs
Water Conservation Efforts
|
gptkbp:training
|
Leadership Development Programs
Technical Skills Training
Continuous Education Programs
|
gptkbp:website
|
www.jnjmedicaldevices.com
|
gptkbp:bfsParent
|
gptkb:Ethicon
|
gptkbp:bfsLayer
|
5
|